Logo image of AVGR

Avinger Inc (AVGR) Stock Price, Forecast & Analysis

USA - NASDAQ:AVGR - US0537348775 - Common Stock

0.474 USD
-0.12 (-20.74%)
Last: 2/14/2025, 8:21:08 PM
0.57 USD
+0.1 (+20.25%)
After Hours: 2/14/2025, 8:21:08 PM

AVGR Key Statistics, Chart & Performance

Key Statistics
Market Cap1.57M
Revenue(TTM)7.26M
Net Income(TTM)-17.35M
Shares3.31M
Float3.05M
52 Week High5.45
52 Week Low0.36
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-11.03
PEN/A
Fwd PEN/A
Earnings (Next)03-18 2025-03-18/amc
IPO2015-01-30
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


AVGR short term performance overview.The bars show the price performance of AVGR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 -40

AVGR long term performance overview.The bars show the price performance of AVGR in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AVGR is 0.474 USD. In the past month the price decreased by -19.65%. In the past year, price decreased by -84.07%.

Avinger Inc / AVGR Daily stock chart

AVGR Latest News, Press Relases and Analysis

AVGR Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES25.23219.11B
ISRG INTUITIVE SURGICAL INC66.92206.56B
BSX BOSTON SCIENTIFIC CORP34.21149.52B
SYK STRYKER CORP26.96135.73B
IDXX IDEXX LABORATORIES INC56.2756.77B
BDX BECTON DICKINSON AND CO12.652.06B
EW EDWARDS LIFESCIENCES CORP32.7249.36B
RMD RESMED INC25.2636.50B
GEHC GE HEALTHCARE TECHNOLOGY16.0133.55B
PODD INSULET CORP70.122.55B
DXCM DEXCOM INC29.4821.51B
ZBH ZIMMER BIOMET HOLDINGS INC10.9717.58B

About AVGR

Company Profile

AVGR logo image Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. The company is headquartered in Redwood City, California and currently employs 68 full-time employees. The company went IPO on 2015-01-30. The firm designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. The company has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).

Company Info

Avinger Inc

400 Chesapeake Dr

Redwood City CALIFORNIA 94063 US

CEO: Jeffrey M. Soinski

Employees: 71

AVGR Company Website

AVGR Investor Relations

Phone: 16503632400

Avinger Inc / AVGR FAQ

What does Avinger Inc do?

Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. The company is headquartered in Redwood City, California and currently employs 68 full-time employees. The company went IPO on 2015-01-30. The firm designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. The company has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).


What is the stock price of Avinger Inc today?

The current stock price of AVGR is 0.474 USD. The price decreased by -20.74% in the last trading session.


Does AVGR stock pay dividends?

AVGR does not pay a dividend.


What is the ChartMill rating of Avinger Inc stock?

AVGR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Which stock exchange lists AVGR stock?

AVGR stock is listed on the Nasdaq exchange.


What is the market capitalization of AVGR stock?

Avinger Inc (AVGR) has a market capitalization of 1.57M USD. This makes AVGR a Nano Cap stock.


What is the ownership structure of Avinger Inc (AVGR)?

You can find the ownership structure of Avinger Inc (AVGR) on the Ownership tab.


AVGR Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AVGR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AVGR. While AVGR seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AVGR Financial Highlights

Over the last trailing twelve months AVGR reported a non-GAAP Earnings per Share(EPS) of -11.03. The EPS increased by 66.4% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -127.59%
ROE -447.82%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%37.67%
Sales Q2Q%-9.19%
EPS 1Y (TTM)66.4%
Revenue 1Y (TTM)-6.3%

AVGR Forecast & Estimates

7 analysts have analysed AVGR and the average price target is 5.1 USD. This implies a price increase of 975.95% is expected in the next year compared to the current price of 0.474.

For the next year, analysts expect an EPS growth of -30.64% and a revenue growth -12.9% for AVGR


Analysts
Analysts82.86
Price Target5.1 (975.95%)
EPS Next Y-30.64%
Revenue Next Year-12.9%

AVGR Ownership

Ownership
Inst Owners1.73%
Ins Owners1.18%
Short Float %N/A
Short RatioN/A